Table 2B.
Cancer Type |
Time (years) |
Standardised |
Group 1a |
Group 2a |
Group 3a |
Group 4a |
Group 5a |
55 |
65 |
75 |
85 |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AIC | BIC | pp | AIC | BIC | AIC | BIC | AIC | BIC | AIC | BIC | AIC | BIC | AIC | BIC | AIC | BIC | AIC | BIC | AIC | BIC | ||
Bladder | 1 | −0.14 | 0.02 | 0.29 | −0.13 | 0.33 | −0.13 | 0.30 | −0.12 | 0.18 | −0.12 | 0.00 | −0.17 | −0.05 | −0.12 | 0.26 | −0.12 | 0.11 | −0.13 | −0.11 | −0.18 | −0.04 |
5 | −0.02 | −0.35 | 0.23 | 0.04 | 0.01 | 0.04 | −0.01 | 0.03 | −0.06 | 0.02 | 0.09 | −0.06 | −0.73 | 0.04 | −0.04 | 0.02 | −0.03 | 0.00 | 0.25 | −0.09 | −1.25 | |
Lung | 1 | −0.25 | −0.15 | −0.11 | −2.30 | −0.13 | −1.08 | −0.10 | 0.74 | −0.03 | −0.82 | −0.05 | −0.10 | −0.28 | 0.35 | −0.06 | −0.10 | −0.02 | 0.07 | −0.13 | −0.45 | −0.39 |
5 | 0.08 | 0.06 | 0.25 | −1.57 | 0.06 | −0.49 | 0.03 | 0.80 | −0.03 | −0.58 | −0.03 | 0.38 | 0.17 | 0.69 | 0.00 | −0.07 | −0.04 | 0.30 | 0.01 | 0.30 | 0.28 | |
Colon | 1 | −0.09 | −0.07 | 0.25 | −0.74 | 0.24 | 0.44 | 0.07 | 0.27 | −0.07 | −0.45 | −0.08 | 0.00 | −0.10 | 0.83 | −0.01 | −0.71 | −0.10 | 1.06 | −0.04 | −1.09 | −0.14 |
5 | 0.03 | 0.00 | 0.33 | −2.69 | −0.01 | 1.53 | 0.04 | 1.10 | 0.05 | −1.09 | −0.03 | 0.38 | 0.00 | 2.83 | 0.06 | −1.81 | 0.03 | 2.88 | −0.10 | −1.74 | 0.08 | |
Rectum | 1 | −0.05 | −0.04 | 0.09 | −0.28 | 1.13 | 0.09 | 0.50 | 0.17 | −0.09 | −0.44 | −0.20 | 0.18 | −0.06 | 0.25 | 0.17 | −0.08 | −0.24 | −0.32 | −0.10 | 0.42 | −0.05 |
5 | −0.02 | −0.10 | 0.25 | −2.70 | −0.32 | 1.01 | −0.19 | 0.44 | −0.06 | −0.51 | 0.00 | 0.11 | −0.18 | 2.17 | −0.12 | −1.94 | −0.01 | 1.46 | −0.01 | −0.36 | −0.32 | |
Stomach | 1 | 0.05 | 0.13 | 0.62 | −1.07 | −0.03 | −0.81 | −0.01 | −0.41 | 0.01 | 0.08 | −0.03 | 0.35 | 0.29 | −0.63 | 0.01 | −0.19 | 0.00 | 0.34 | −0.04 | 0.31 | 0.52 |
5 | 0.07 | −0.08 | 0.29 | 0.19 | 0.09 | 0.18 | 0.02 | 0.14 | −0.01 | 0.05 | 0.08 | 0.05 | −0.21 | 0.17 | −0.01 | 0.11 | 0.01 | −0.01 | 0.12 | 0.11 | −0.49 | |
Melanoma | 1 | −0.01 | −0.05 | 0.17 | −0.01 | −0.07 | −0.17 | −0.03 | 0.31 | 0.05 | −0.02 | 0.11 | −0.17 | −0.27 | 0.12 | 0.00 | 0.23 | 0.09 | −0.22 | 0.08 | −0.17 | −0.44 |
5 | −0.13 | −0.15 | 0.00 | −0.02 | −0.03 | −0.26 | −0.05 | 0.41 | −0.02 | −0.21 | −0.02 | −0.48 | −0.50 | 0.19 | −0.04 | 0.12 | 0.00 | −0.13 | −0.09 | −0.71 | −0.74 | |
Prostate | 1 | −0.20 | −0.19 | −0.10 | −0.10 | −0.07 | −0.04 | −0.04 | −0.09 | −0.06 | −0.21 | −0.24 | −1.17 | −1.04 | −0.07 | −0.06 | −0.04 | −0.04 | −0.16 | −0.11 | −0.55 | −0.65 |
5 | −0.01 | 0.01 | 0.08 | −0.36 | −0.02 | 0.24 | 0.00 | −0.40 | 0.00 | 0.46 | 0.00 | −0.28 | 0.12 | −0.01 | −0.01 | 0.08 | 0.00 | −0.41 | −0.01 | 0.98 | 0.06 | |
Hodgkins | 1 | 0.13 | 0.13 | 0.27 | 0.01 | 0.01 | 0.06 | 0.06 | 0.16 | 0.16 | 0.32 | 0.32 | 0.52 | 0.52 | 0.10 | 0.10 | 0.24 | 0.24 | 0.44 | 0.44 | 0.59 | 0.59 |
5 | 0.00 | 0.00 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | −0.01 | −0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | −0.02 | −0.02 |
The five groups used for the age-group estimates were 18–44, 45–54, 55–64, 65–74 and 75+. Age-group estimates for prostate cancer were however obtained for the groups 18–54, 55–64, 65–74, 75–84 and 85+.